Literature DB >> 16122650

Empirical antimicrobial therapy for odontogenic infections.

Jacobo Limeres, I Tomás, M Alvarez, Pedro Diz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16122650     DOI： 10.1016/j.tripleo.2004.12.019

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN： 1079-2104


× No keyword cloud information.
  6 in total

1.  Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.

Authors:  P Diz Dios; I Tomás Carmona; J Limeres Posse; J Medina Henríquez; J Fernández Feijoo; M Alvarez Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.

Authors:  B Al-Nawas; C Walter; T Morbach; N Seitner; E Siegel; M Maeurer; F Krummenauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

3.  Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.

Authors:  Georg Cachovan; Rainer H Böger; Ina Giersdorf; Olaf Hallier; Thomas Streichert; Munif Haddad; Ursula Platzer; Gerhard Schön; Karl Wegscheider; Ingo Sobottka
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

4.  Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure.

Authors:  C Pigrau; B Almirante; D Rodriguez; N Larrosa; S Bescos; G Raspall; A Pahissa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-17       Impact factor: 3.267

5.  Cefazolin versus ampicillin/sulbactam as an empiric antibiosis in severe odontogenic neck infection descending from the lower jaw-retrospective analysis of 350 cases.

Authors:  Johannes Buller; Matthias Kreppel; Matthias Zirk; Joachim E Zoeller; Franziska Peters; Linda Ringendahl
Journal:  Clin Oral Investig       Date:  2020-08-10       Impact factor: 3.573

6.  Moxifloxacin versus Clindamycin/Ceftriaxone in the management of odontogenic maxillofacial infectious processes: A preliminary, intrahospital, controlled clinical trial.

Authors:  Hansel Gómez-Arámbula; Antonio Hidalgo-Hurtado; Rosaura Rodríguez-Flores; Ana-María González-Amaro; Arturo Garrocho-Rangel; Amaury Pozos-Guillén
Journal:  J Clin Exp Dent       Date:  2015-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.